קם-רהו די I.M

देश: इसराइल

भाषा: हिब्रू

स्रोत: Ministry of Health

सक्रिय संघटक:

ANTI-D IMMUNOGLOBULINS

थमां उपलब्ध:

KAMADA LTD, ISRAEL

ए.टी.सी कोड:

J06BB01

फार्मास्यूटिकल फॉर्म:

תמיסה להזרקה

रचना:

ANTI-D IMMUNOGLOBULINS 150 MCG/ML

प्रशासन का मार्ग:

תוך-שרירי

प्रिस्क्रिप्शन प्रकार:

מרשם נדרש

द्वारा बनाया गया:

KAMADA LTD, ISRAEL

चिकित्सीय समूह:

ANTI-D (RH) IMMUNOGLOBULIN

चिकित्सीय क्षेत्र:

ANTI-D (RH) IMMUNOGLOBULIN

चिकित्सीय संकेत:

Pregnancy/other obstetric conditions, Suppression of Rh immunization in non-sensitized Rh0 (D) negative women delivering an Rh0 positive baby or when the baby's Rh type is unknown. Suppression of Rh immunization after spontaneous or induced abortions threatened abortion associated with maternal bleeding amniocentesis chorionic villus sampling ruptured tubal pregnancy and significant abdominal trauma. Kam Rh0 -D IM should be given within 72 hours of the event. It may be given even after up to one month although efficacy may be somewhat reduced.Transfusion: Suppression of Rh isoimmunization in Rh0 (D) antigen-negative patients transfused with Rh0 (D) antigen-positive RBCs of blood components containing Rh0 (D) antigen-positive RBCs . Initate treatment within 72 hours of exposure.

प्राधिकरण की तारीख:

2022-01-31